Twice-weekly high-dose rHuEpo for the treatment of anemia in patients with low-risk myelodysplastic syndromes
- PMID: 18974634
- DOI: 10.1159/000166864
Twice-weekly high-dose rHuEpo for the treatment of anemia in patients with low-risk myelodysplastic syndromes
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
